In this issue:
Prior biologic use and efficacy of brodalumab/ustekinumab in plaque psoriasis
Risk of incident liver disease in psoriasis, PsA, and RA
Calcipotriol/betamethasone foam effective in plaque psoriasis
Apremilast for moderate-to-severe palmoplantar psoriasis
Etanercept biosimilar efficacy in chronic plaque psoriasis
Latent tuberculosis in patients treated with TNF inhibitors
Meta-analysis of the interleukin (IL)-12/23 and IL-17 inhibitors
Japanese epidemiological survey of psoriatic patients
Intentional and unintentional medication non-adherence in psoriasis
Please login below to download this issue (PDF)